Patterns of tumor progression in a phase 3 study of bevacizumab (Bv) plus radiotherapy (RT) plus temozolomide (T) for newly diagnosed glioblastoma (GB).
Wolfgang Wick
Consultant or Advisory Role - Lilly (U); MSD; Roche
Research Funding - Apogenix; Boehringer Ingelheim; Lilly; MSD; Roche
Olivier L. Chinot
Consultant or Advisory Role - Roche
Honoraria - AstraZeneca; MSD; Roche
Research Funding - Roche; Schering-Plough
Warren P. Mason
Consultant or Advisory Role - Roche
Roger Henriksson
Consultant or Advisory Role - Roche
Frank Saran
Consultant or Advisory Role - Roche
Ryo Nishikawa
Consultant or Advisory Role - Roche
Cedric Revil
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche
Research Funding - Roche/Genentech
Yannick Kerloeguen
Employment or Leadership Position - Roche/Genentech
Timothy Francis Cloughesy
Consultant or Advisory Role - Apogenix; Celgene; Genentech; Merck; Merck Serono; NewGen Therapeutics; Roche; Tocagen